Jake Simson

Partner, RA Capital Management

Jake Simson is a Partner at RA Capital Management working on both public and private investments and serving as a Board Director for Janux Therapeutics, Tyra Biosciences, Bicara Therapeutics, Convergent Therapeutics, Septerna, Outpace Bio, and Vivace Therapeutics. Previously, Jake covered solid tumor oncology landscapes. Jake holds a B.S. in materials science and engineering from MIT and a Ph.D. in biomedical engineering from Johns Hopkins University. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels.